Edition:
United Kingdom

DelMar Pharmaceuticals Inc (DMPI.OQ)

DMPI.OQ on NASDAQ Stock Exchange Capital Market

1.28USD
19 Jul 2019
Change (% chg)

$-0.07 (-5.19%)
Prev Close
$1.35
Open
$1.34
Day's High
$1.36
Day's Low
$1.28
Volume
4,504
Avg. Vol
58,461
52-wk High
$8.50
52-wk Low
$1.19

About

DelMar Pharmaceuticals, Inc. is a clinical-stage drug development company. The Company focuses on the treatment of cancer. The Company is engaged in conducting clinical trials in the United States with its product candidate, VAL-083, as a treatment for glioblastoma multiforme (GBM), a form of brain cancer. VAL-083 is being... (more)
No analyst recommendations are available for .

Overall

Beta: 0.83
Market Cap(Mil.): $5.17
Shares Outstanding(Mil.): 3.83
Dividend: --
Yield (%): --

Financials

  DMPI.OQ Industry Sector
P/E (TTM): -- 12.13 22.22
EPS (TTM): -3.36 -- --
ROI: -175.80 6.30 0.33
ROE: -- 8.35 16.33

Earnings vs. Estimates